| Chronic Fatigue Syndrome |
| Written by Dr. Tel-Oren |
|
Chronic, persistent or relapsing debilitating fatigue or easily fatigued, that does not resolve with bed rest and that is severe enough to reduce or impair average daily activity below 50% of premorbid activity level. Associated symptoms: mild fever, sore throat, painful lymph nodes, muscle weakness, myalgia headaches, arthralgia, neuro- psychological complaints, sleep disturbances.
International CFS Study Group Definition of Chronic Fatigue Syndrome I. Clinically evaluated, unexplained persistent or relapsing chronic fatigue that:
II. The concurrent occurrence of four or more of the following symptoms, all of which must have persisted or recurred during six or more consecutive months of illness and must not have predated the fatigue:
reduction in previous levels of occupational, educational, social, or personal activities sore throat
Suspected Etiologies for Chronic Fatigue Syndrome
Factors Suspected of Promoting Chronic Fatigue Syndrome
Symptoms Fatigue: The degree may be mild, being able to perform at work or home but easily fatigued from it; or it may be intense, causing patients to give up their jobs and greatly curtailing other activities. Sometimes they may be bedridden, and slight activities such as housecleaning or going for a walk may necessitate a recovery period of 2-3 days. Usually more strenuous exertion and exercising are impossible. Frequently, though, patients have alternating periods of fatigue and normalcy. The disease usually begins gradually, with the fatigue slowly growing until it becomes overwhelming. Other symptoms include:
difficulty sleeping, weight loss or gain Lab Findings While laboratory diagnosis of this condition used to be prohibitively expensive and inadequate, some labs now provide reasonably priced comprehensive panels showing titers of different causative agents, usually Epstein-Barr virus, Cytomegalovirus, toxoplasmosis, Candida. Subtyping of antigens allows accurate diagnosis of present, chronic, active or inactive infections, but severity of symptoms do not always correlate with the lab findings. Some patients with extremely high titers for a particular agent may be symptom-free while others with low titers may be extremely symptomatic. Many see decreased WBC count, increased lymphs or atypical lymphs on peripheral smear.
Course and Prognosis This disorder is not well recognized by most conventional physicians, despite empirical evidence and clinical research. Conventional treatment involves suppression and/or palliation of symptoms, e.g. salicylates for fever, headaches, and myalgia. With no further diagnosis or treatment the patient is likely to have bouts of remissions and exacerbations that may develop into a constant, persistent disease. Appropriate diagnosis and treatment lead to excellent recovery rates in most sufferers who comply.
Nutrients Involved Vitamin B12 Note: CFS patients generally have B12 metabolism problems requiring much higher B12 supplementation. Sublingual magnesium assessment is more indicative of magnesium status as the cells (sublingual) are increasing turnover cells with mitochondria vs. RBC have no mitochondria (CFS patients have energy production problems).
Suggested Nutritional Supplementation
section for specifics)
EPA-DHA 720 provides 720 mg of omega-3 essential fatty acids from cold water fish per softgel- eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Mitochondrial Resuscitate is scientifically designed to provide nutritional support for healthy cellular energy (ATP) production.
Stabilized, Highly Absorbable Coenzyme Q10 with Natural Vitamin E and Beta-Carotene
Intrinsi B12/Folate provides vitamin B12 and folates in combination with intrinsic factor for enhanced absorption and assimilation
pH Correct Creatine for increased muscle ATP.
Dietary Suggestions
Avoid:
*Viral protein structures are arginine rich vs. human protein structures which are lysine rich (e.g., CFS patients in general have decreased arginine by amino acid analysis possibly because of increased viral replication.) |
| Last Updated on Friday, 30 January 2009 05:25 |